These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 27622341)
1. Increased Expression of HYAL1 in Pancreatic Ductal Adenocarcinoma. Kohi S; Sato N; Cheng XB; Koga A; Hirata K Pancreas; 2016 Nov; 45(10):1467-1473. PubMed ID: 27622341 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronan stimulates pancreatic cancer cell motility. Cheng XB; Kohi S; Koga A; Hirata K; Sato N Oncotarget; 2016 Jan; 7(4):4829-40. PubMed ID: 26684359 [TBL] [Abstract][Full Text] [Related]
3. A novel epigenetic mechanism regulating hyaluronan production in pancreatic cancer cells. Kohi S; Sato N; Cheng XB; Koga A; Higure A; Hirata K Clin Exp Metastasis; 2016 Mar; 33(3):225-30. PubMed ID: 26589701 [TBL] [Abstract][Full Text] [Related]
4. Hyaluronan activated-metabolism phenotype (HAMP) in pancreatic ductal adenocarcinoma. Kudo Y; Kohi S; Hirata K; Goggins M; Sato N Oncotarget; 2019 Sep; 10(54):5592-5604. PubMed ID: 31608136 [No Abstract] [Full Text] [Related]
5. Hypoxia increases KIAA1199/CEMIP expression and enhances cell migration in pancreatic cancer. Oba T; Sato N; Adachi Y; Amaike T; Kudo Y; Koga A; Kohi S; Hirata K Sci Rep; 2021 Sep; 11(1):18193. PubMed ID: 34521918 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of transmembrane protein 2 (TMEM2), a novel hyaluronidase, predicts poor prognosis in pancreatic ductal adenocarcinoma. Kudo Y; Sato N; Adachi Y; Amaike T; Koga A; Kohi S; Noguchi H; Nakayama T; Hirata K Pancreatology; 2020 Oct; 20(7):1479-1485. PubMed ID: 32948431 [TBL] [Abstract][Full Text] [Related]
7. Negative regulation between the expression levels of receptor for hyaluronic acid-mediated motility and hyaluronan leads to cell migration in pancreatic cancer. Cheng XB; Wang S; Yang H; Tong H; Shi G; Wu L; Zhou J; Shi L; Li H; Ren S; Zhou Y; Sato N Oncol Lett; 2020 Nov; 20(5):199. PubMed ID: 32963605 [TBL] [Abstract][Full Text] [Related]
8. KIAA1199 is induced by inflammation and enhances malignant phenotype in pancreatic cancer. Kohi S; Sato N; Koga A; Matayoshi N; Hirata K Oncotarget; 2017 Mar; 8(10):17156-17163. PubMed ID: 28179576 [TBL] [Abstract][Full Text] [Related]
9. High-molecular-weight hyaluronan produced by activated pancreatic stellate cells promotes pancreatic cancer cell migration via paracrine signaling. Junliang L; Lili W; Xiaolong L; Xuguang L; Huanwen W; Zhiyong L Biochem Biophys Res Commun; 2019 Jul; 515(3):493-498. PubMed ID: 31171359 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronidase 1 and hyaluronidase 2 are required for renal hyaluronan turnover. Colombaro V; Jadot I; Declèves AE; Voisin V; Giordano L; Habsch I; Flamion B; Caron N Acta Histochem; 2015 Jan; 117(1):83-91. PubMed ID: 25468725 [TBL] [Abstract][Full Text] [Related]
11. Decreased hyaluronidase 1 expression is associated with early disease recurrence in human endometrial cancer. Nykopp TK; Pasonen-Seppänen S; Tammi MI; Tammi RH; Kosma VM; Anttila M; Sironen R Gynecol Oncol; 2015 Apr; 137(1):152-9. PubMed ID: 25584766 [TBL] [Abstract][Full Text] [Related]
12. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360 [TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma. Cheng XB; Sato N; Kohi S; Yamaguchi K PLoS One; 2013; 8(11):e80765. PubMed ID: 24244714 [TBL] [Abstract][Full Text] [Related]
14. Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice. Simpson MA Am J Pathol; 2006 Jul; 169(1):247-57. PubMed ID: 16816377 [TBL] [Abstract][Full Text] [Related]
15. HYAL1 overexpression is correlated with the malignant behavior of human breast cancer. Tan JX; Wang XY; Li HY; Su XL; Wang L; Ran L; Zheng K; Ren GS Int J Cancer; 2011 Mar; 128(6):1303-15. PubMed ID: 20473947 [TBL] [Abstract][Full Text] [Related]
16. Concurrent Overexpression of Two Hyaluronidases, KIAA1199 and TMEM2, Strongly Predicts Shorter Survival After Resection in Pancreatic Ductal Adenocarcinoma. Kudo Y; Sato N; Oba T; Adachi Y; Amaike T; Koga A; Kohi S; Noguchi H; Nakayama T; Hirata K Pancreas; 2022 Aug; 51(7):800-807. PubMed ID: 36395406 [TBL] [Abstract][Full Text] [Related]
17. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. Lokeshwar VB; Rubinowicz D; Schroeder GL; Forgacs E; Minna JD; Block NL; Nadji M; Lokeshwar BL J Biol Chem; 2001 Apr; 276(15):11922-32. PubMed ID: 11278412 [TBL] [Abstract][Full Text] [Related]
18. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma. Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420 [TBL] [Abstract][Full Text] [Related]
19. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice. Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin. Zhao X; Gao S; Ren H; Sun W; Zhang H; Sun J; Yang S; Hao J Cancer Res; 2014 May; 74(9):2455-64. PubMed ID: 24599125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]